Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Inquiry Memorial
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • The Inquiry Report
    • Additional Compensation Report
    • First Interim Report
    • Second Interim Report
    • Compensation Framework Study
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • Support and FAQs
    • NHS Psychological Support
    • Support Groups
    • Infected Blood Support Schemes
    • Hepatitis C Testing
  • Contact us
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Subscribe to Search results

The minutes of a meeting held at NIBSC highlighted that the issue of withdrawal was not approached purely as a scientific one, but as a question of policy that took into account concerns pertaining to economics and the perceived need to maintain the supply of fractionated blood products.

Published on: 27 August, 2024

Patient information leaflets became a legal requirement in the UK for all medicines.

Published on: 27 August, 2024

Cutter confirmed that all plasma was being collected from FDA licensed and inspected centres.

Published on: 27 August, 2024

William Srigley of Cutter Pharmaceutical gave evidence that he was aware before July 1982 that a homosexual donor who was hepatitis positive risked transmitting AIDS.

Published on: 27 August, 2024

The evidence is that after February 1983 any remaining stocks of factor concentrates that had been prepared by Cutter using prison plasma were used for research and development purposes only.

Published on: 17 October, 2024

"The New England Journal of Medicine", published an article by Gottlieb et al titled "Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men".

Published on: 27 August, 2024

The New England Journal of Medicine published an article by Masur et al titled "An outbreak of community-acquired pneumocystis carinii pneumonia".

Published on: 27 August, 2024

The New England Journal of Medicine published an article by Durack titled "Opportunistic infections and Kaposi's sarcoma in homosexual men".

Published on: 27 August, 2024

Strategy caucuses of the plasma collection and manufacturing interests in advance of their meeting regulators, the CDC and others were to become a common occurrence.

Published on: 27 August, 2024

Dr Ojala's (Cutter) memo of a meeting on non-specific (surrogate) testing concluded: "In summary, the conclusion of this meeting was that the time had come for Hepatitis core anti-body testing for plasma. Implementation will probably be achieved during 1984 for the industry."

Published on: 27 August, 2024

Dr Ojala's (Cutter) memo of a meeting on non-specific (surrogate) testing stated: "The approval of our heat-treat submission, in conjunction with core-screened plasma could present us with a potent marketing advantage. We made no mention of our plans to the others."

Published on: 27 August, 2024

The New England Journal of Medicine published an article by Siegal et al titled "Severe Acquired Immunodeficiency in Male Homosexuals, Manifested by Chronic Perianal Ulcerative Herpes Simplex Lesions".

Published on: 18 October, 2024

Inquiry publishes financial report

Published on: 28 August, 2024

Rhys Brennan

Published on: 25 February, 2025

At an Association of Haematologists North East Thames Region Working Party in Haemophilia meeting, Dr Lane "projected utilisation of factor VIII concentrate to grow to 60M iu [international units] per annum over a ten-year period" but suggested "100M iu per annum" as a more realistic estimate to achieve self-sufficiency.

Published on: 17 October, 2024

It was apparent that the fractionation capacity in England would need significant expansion.

Published on: 30 August, 2024

A Working Party on Human Antihaemophilic Globulin meeting determined "As the HAHG [human antihaemophilic globulin] concentrate prepared from plasma pools of up to 30-40 litres in volume apparently carried a risk of transmitting serum hepatitis, it was considered inadvisable...to increase the plasma pool volume much above this size".

Published on: 17 October, 2024

There was an upward shift in estimates of future needs, though slighter on this occasion. Current demand for Factor 8 was probably in the region of 60 million international units but, if clinical freedom continued, it could reach 100 million international units per annum.

Published on: 30 August, 2024

Alec Parrott wrote a letter to Susan Maunsell proposing a solution to the problem of securing an agreement acceptable to the workforce if asked to run a 24- hour shift system.

Published on: 30 August, 2024

Dr Maycock published "Present Sources of Materials for Treatment of Haemophilia and Potential Future Sources" showing the limits of fractionation capacity contributing to blood product shortfall; in order to meet the preferred number of units of cryoprecipitate and factor concentrates, capacity would have to increase by 800L a week.

Published on: 30 August, 2024

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 2092
  • Page 2093
  • Page 2094
  • Page 2095
  • Current page 2096
  • Page 2097
  • Page 2098
  • Page 2099
  • Page 2100
  • …
  • Next page Next
  • Last page Last

Inquiry

  • Home
  • About
  • Approach
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.